Royalty Pharma plc Class A Ordinary Shares vs Unusual Machines Inc. Common Stock — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $59.03 (market cap $25.18B), while Unusual Machines Inc. Common Stock trades at $17.44 (market cap $971.15M). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 25.9× Unusual Machines Inc. Common Stock's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Unusual Machines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 6 Days and Unusual Machines Inc. Common Stock for 0 Days on average.
| RPRX | UMAC | |
|---|---|---|
Market Cap | $25.18B | $971.15M |
Volume | 3,399,248 | 3,714,986 |
Sector | Health | Technology |
52-Week High | $63.96 | $34.06 |
52-Week Low | $36.18 | $7.76 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $32.42B | $657.94M |
Dividend Yield | 1.66% | — |
Signals from Pluang's Aura AI — not financial advice
Royalty Pharma (RPRX) trades at $56.57, down 2.09% on the day, with a bullish technical signal and strong fundamentals. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue and net income show steady growth, supported by a high gross profit margin of 89.38%. Analyst consensus is unanimously bullish with a $63.33 price target.
The outlook remains positive given earnings momentum and strategic capital deployment, though risks include biopharma policy shifts and reliance on partner drug performance. The stock offers exposure to a diversified portfolio of blockbuster drugs with minimal operational risk, but investors should monitor upcoming earnings and broader sector dynamics.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →Unusual Machines Inc. manufactures and sells drone components and complete drones for consumer, enterprise, and defense markets, operating brands including Fat Shark FPV goggles and the Rotor Riot retail platform, with US-based, NDAA-compliant manufacturing.
Read more on UMAC →